Professor Yuen's research interests include prevention, natural history, serology, virology and treatment of chronic hepatitis B and C, and hepatocellular carcinoma.
He is one of the top internationally renowned researchers in the field of hepatitis B disease. He has now published more than 560 papers in world-renowned medical journals including New England Journal of Medicine, Lancet, Nature Medicine, Lancet Infectious Diseases and Lancet Oncology. According to the Expertscape online platform examining 25,130 publications during the period between 2013 and 2023, he is now ranked the top 1 researcher under the category of “hepatitis B”
As a world-class clinician scientist, Professor Yuen is now leading most of the international trials examining new drugs including antiviral and immunomodulatory agents for the treatment of chronic hepatitis B. He is also actively performing cutting-edge research on novel markers for hepatitis B infection and occult hepatitis B infection. With all these international academic and professional achievements, Professor Yuen is an invited member serving as key opinion leader for several international coalition committees including the International Coalition to Eliminate HBV (ICE-HEP) and Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) on hepatitis B disease.